{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T02:10:02Z","timestamp":1751681402403,"version":"3.41.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2008\/01296-2"],"award-info":[{"award-number":["2008\/01296-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["306209\/2009-8"],"award-info":[{"award-number":["306209\/2009-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008353","name":"FAEPA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.exppara.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T14:51:08Z","timestamp":1528469468000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis"],"prefix":"10.1016","volume":"191","author":[{"given":"Nat\u00e1llia Alle","family":"Parreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-466X","authenticated-orcid":false,"given":"Fernando Silva","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlei Josiele","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deisy Mara","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cibele Maria","family":"Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Elias J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanderlei","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3486-5294","authenticated-orcid":false,"given":"Leandra N\u00e1ira Zambelli","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2018.05.004_bib1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/hepr.12081","article-title":"Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model","volume":"43","author":"Aihara","year":"2013","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.exppara.2018.05.004_bib2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0046-8177(92)90135-P","article-title":"Hepatic connective tissue changes in hepatosplenic schistosomiasis","volume":"23","author":"Andrade","year":"1992","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.exppara.2018.05.004_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1756-3305-6-199","article-title":"Telmisartan, an AT1 receptor blocker and a PPAR-gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection","volume":"5","author":"Attia","year":"2013","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.exppara.2018.05.004_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.hjh.0000202812.72341.99","article-title":"Renin inhibition with aliskiren: where are we now and where are we going?","volume":"24","author":"Azizi","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.exppara.2018.05.004_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02915100","article-title":"Role of fat-storing cells in schistosomal hepatic fibrosis of mice","volume":"64","author":"Barbosa J\u00fanior","year":"1993","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"10.1016\/j.exppara.2018.05.004_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.peptides.2012.07.020","article-title":"Endothelium dependent expression and underlying mechanisms of des-Arg\u2079-bradykinin-induced B\u2081R-mediated vasoconstriction in rat portal vein","volume":"37","author":"Basei","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.exppara.2018.05.004_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exppara.2018.05.004_bib8","first-page":"125","article-title":"The histopathology of early hepatic schistosomiasis","volume":"5","author":"Bhagwandeen","year":"1976","journal-title":"Afr. J. Med. Med. Sci."},{"key":"10.1016\/j.exppara.2018.05.004_bib9","first-page":"505","article-title":"Experimental schistosomiasis mansoni: characterization of connective tissue cells in hepatic periovular granulomas","volume":"25","author":"Boloukhere","year":"1993","journal-title":"J. Submicr. Cytol. Pathol."},{"key":"10.1016\/j.exppara.2018.05.004_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(99)10365-9","article-title":"Angiotensin ll receptor antagonist","volume":"355","author":"Burnier","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2018.05.004_bib11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1478-3231.2011.02695.x","article-title":"Aliskiren reduces portal pressure in cirrhotic rats","volume":"32","author":"Chang","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.exppara.2018.05.004_bib12","first-page":"1","article-title":"Progress in assessment of morbidity due to Schistosoma mansoni infection. A review of recent literature","volume":"85","author":"Chen","year":"1988","journal-title":"Trop. Dis. Bull."},{"key":"10.1016\/j.exppara.2018.05.004_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","article-title":"The global status of schistosomiasis and its control","volume":"77","author":"Chitsulo","year":"2000","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2018.05.004_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1440-1681.2011.05575.x","article-title":"Potential antifibrotic effects of AT1 receptor antagonist, losartan, and\/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni","volume":"38","author":"El-Lakkany","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.exppara.2018.05.004_bib15","series-title":"Miller's Anatomy of the Dog","first-page":"1113","author":"Evans","year":"1993"},{"key":"10.1016\/j.exppara.2018.05.004_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/CS20120030","article-title":"Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options","volume":"123","author":"Grace","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.exppara.2018.05.004_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2013.06.036","article-title":"Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis","volume":"145","author":"Grace","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exppara.2018.05.004_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00535-016-1190-4","article-title":"Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights","volume":"51","author":"Greuter","year":"2016","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.exppara.2018.05.004_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2008-1040707","article-title":"The pathophysiology of portal hypertension: a basis for classification","volume":"2","author":"Groszmann","year":"1982","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.exppara.2018.05.004_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/ajpgi.00163.2012","article-title":"Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver","volume":"304","author":"Herath","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.exppara.2018.05.004_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcma.2012.07.001","article-title":"Aliskiren reduces portal pressure and intrahepatic resistance in biliary cirrhotic rats","volume":"75","author":"Hsieh","year":"2012","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.exppara.2018.05.004_bib22","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.exppara.2018.05.004_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biopha.2007.10.020","article-title":"Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats","volume":"62","author":"Karimian","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exppara.2018.05.004_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1590\/S0037-86822000000300009","article-title":"An\u00e1lise cr\u00edtica da estimativa do n\u00famero de portadores de esquistossomose no Brasil","volume":"33","author":"Katz","year":"2000","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.exppara.2018.05.004_bib25","first-page":"1069","article-title":"The hepatic perisinusoidal stellate cell","volume":"12","author":"Kawada","year":"1997","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.exppara.2018.05.004_bib26","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.cellsig.2008.06.021","article-title":"Bradykinin-induced expression of alpha-smooth muscle actin in human mesenchymal stem cells","volume":"20","author":"Kim","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.exppara.2018.05.004_bib27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00003088-199834060-00003","article-title":"Clinical pharmacokinetics of vasodilators. Part I","volume":"34","author":"Kirsten","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.exppara.2018.05.004_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/hepr.12186","article-title":"Therapeutic effects of the direct renin inhibitor, aliskiren, on non-alcoholic steatohepatitis in fatty liver Shionogi ob\/ob male mice","volume":"44","author":"Kishina","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.exppara.2018.05.004_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138732","article-title":"Hemodynamic effects of the non-peptidic Angiotensin-(1-7) agonist AVE0991 in liver cirrhosis","volume":"10","author":"Klein","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2018.05.004_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s004180050421","article-title":"Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair","volume":"112","author":"Knittel","year":"1999","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.exppara.2018.05.004_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.exppara.2018.05.004_bib32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2362.2012.02725.x","article-title":"Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice","volume":"42","author":"Lee","year":"2012","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.exppara.2018.05.004_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","article-title":"Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis","volume":"26","author":"Liu","year":"2006","journal-title":"Liver Int."},{"key":"10.1016\/j.exppara.2018.05.004_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.exppara.2007.06.002","article-title":"Schistosoma mansoni: TGF-beta signaling pathways","volume":"117","author":"Loverde","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2018.05.004_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1515\/BC.2006.027","article-title":"The role of bradykinin B1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP)","volume":"387","author":"Moniwa","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.exppara.2018.05.004_bib36","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.23419","article-title":"Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats","volume":"51","author":"Moreno","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.exppara.2018.05.004_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1386-6346(01)00102-4","article-title":"Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats","volume":"21","author":"Ohishi","year":"2001","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.exppara.2018.05.004_bib38","first-page":"59","article-title":"Comparison of different blockages on the renin angiotensin system in murine schistosomal fibrosis","volume":"2","author":"Parreira","year":"2014","journal-title":"Global J. Pathol. Microbiol."},{"key":"10.1016\/j.exppara.2018.05.004_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0676.1998.tb00120.x","article-title":"Signal transduction in hepatic stellate cells","volume":"18","author":"Pinzani","year":"1998","journal-title":"Liver"},{"key":"10.1016\/j.exppara.2018.05.004_bib40","first-page":"1499","article-title":"Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis in rats","volume":"49","author":"Ramalho","year":"2002","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.exppara.2018.05.004_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13098-017-0282-5","article-title":"Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome","volume":"9","author":"Ramalho","year":"2017","journal-title":"Diabetol. Metab. Syndrome"},{"key":"10.1016\/j.exppara.2018.05.004_bib42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/hep.510270539","article-title":"Life or death: the fate of the hepatic stellate cell following hepatic injury","volume":"27","author":"Rippe","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.exppara.2018.05.004_bib43","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1053\/j.gastro.2007.09.023","article-title":"Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury","volume":"133","author":"Sancho-Bru","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exppara.2018.05.004_bib44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000313363","article-title":"Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease","volume":"31","author":"Siragy","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.exppara.2018.05.004_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0016-5085(97)70105-7","article-title":"Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells","volume":"113","author":"Sprenger","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.exppara.2018.05.004_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","article-title":"Mechanisms of liver fibrosis","volume":"364","author":"Tsukada","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.exppara.2018.05.004_bib47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10620-007-9941-y","article-title":"Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis","volume":"53","author":"T\u00fcrkay","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.exppara.2018.05.004_bib48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3748\/wjg.v6.i6.824","article-title":"The regulatory role of AT1 receptor on activated HSC in hepatic fibrogenesis: effects of RAS inhibitors on hepatic fibrosis induced by CCl(4)","volume":"6","author":"Wei","year":"2000","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.exppara.2018.05.004_bib49","first-page":"19","article-title":"The significance of angiotensin l converting enzyme in granulomatous inflammation. Functions of ace in granulomas","volume":"3","author":"Weinstock","year":"1986","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.exppara.2018.05.004_bib50","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1152\/ajprenal.00192.2010","article-title":"A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren","volume":"299","author":"Wu","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.exppara.2018.05.004_bib51","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.4238\/2015.December.29.17","article-title":"Glucagon-like peptide-1 receptor agonists inhibit hepatic stellate cell activation by blocking the p38 MAPK signaling pathway","volume":"14","author":"Wu","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.exppara.2018.05.004_bib52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10557-011-6339-z","article-title":"Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice","volume":"25","author":"Ye","year":"2011","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.exppara.2018.05.004_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1440-1746.2006.04663.x","article-title":"Blockade of renin-angiotensin system in antifibrotic therapy","volume":"22","author":"Yoshiji","year":"2007","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489417306446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489417306446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T01:36:10Z","timestamp":1751679370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489417306446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":53,"alternative-id":["S0014489417306446"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2018.05.004","relation":{},"ISSN":["0014-4894"],"issn-type":[{"type":"print","value":"0014-4894"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}